None listed
Conditions
Brief summary
People with pulmonary fibrosis (PF) are 70% less active than healthy individuals. Low levels of physical activity increases fatigue and worsens breathlessness and quality of life. Pulmonary rehabilitation is a recommended intervention to improve physical function, breathlessness, and quality of life in people with PF. Finding strategies that prolong the benefits of pulmonary rehabilitation such as improving physical activity are needed. This study will explore whether a physical activity counselling session, combined with using a physical activity tracker can increase physical activity levels and make pulmonary rehabilitation benefits last longer in people with PF.
Interventions
Participants will receive one counselling session, in-person or remotely, conducted by a trained researcher (approximately one-hour). The counselling will follow the behaviour change principles of capability, opportunity and motivation model including education about the importance of being physically active, how to improve physical activity (PA) and keep motivated. A Fitbit, an 8-week individualized step goal based on the 6MWT and an information leaflet on the benefits of PA according to Austra
Participants will receive one counselling session, in-person or remotely, conducted by a trained researcher (approximately one-hour). The counselling will follow the behaviour change principles of capability, opportunity and motivation model including education about the importance of being physically active, how to improve physical activity (PA) and keep motivated. A Fitbit, an 8-week individualized step goal based on the 6MWT and an information leaflet on the benefits of PA according to Australian Department of Health will be given following the session. It is expected that follow-up calls will take approximately 30-minutes. Participants will receive follow-up phone calls at 4 and 8 weeks for PA behavioural reinforcement. After 8-weeks, participants will be allowed to keep the Fitbit, however no further individual goal setting will occur.
Sponsors
Centre of Research Excellence in Pulmonary Fibrosis
Study design
Allocation
Randomised controlled trial
Primary purpose
Treatment
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Participants aged 18 years and over with a confirmed diagnosis of PF, able to read and speak English and provide informed consent.
Exclusion criteria
Patients will be if they have a significant cognitive impairment, are unable to use the physical activity tracker or accompanying app or if there is an anticipated transplant or death within the duration of the study period
Outcome results
None listed